MDM2, as a well-known oncogene, may also promote type 17 T-helper cell differentiation by suppressing p53-dependent transcription factor STAT5 signaling cascades, leading to activation of rheumatoid arthritis [35, 36]. The gene discussed is TP53; the disease is rheumatoid arthritis.